Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Belantamab mafodotin
Lenalidomide
Locations
1
United States
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
December 1, 2022
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
March 5, 2026
NCT04268199
NCT07236021
NCT05932680
NCT06911710
NCT04782687
NCT03891914
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions